JPET Highlight: Attenuation of chemotherapy-induced peripheral neuropathy by etodolac
Posted on 1/1/0001 12:00:00 AM
|
Tags:
The antiallodynic effect of etodolac increases upon repeated administration; therefore, along with safer long-term use it may also attenuate the adverse neurological effects of paclitaxel chemotherapy. See article atJ Pharmacol Exp Ther 2012, 342:53-60.
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics